Insider Trading & Ownership of Joseph Hernandez

Location
New York, NY
Summary
The estimated net worth of Joseph Hernandez is at least $15,808,160 dollars as of 24 Mar 2026. Joseph Hernandez is the CEO, Director, 10%+ Owner of Blue Water Biotech, Inc. and owns shares of Onconetix, Inc. (ONCO) stock worth about $11.49M. Joseph Hernandez is the Chief Executive Officer, Director, 10%+ Owner of Blue Water Acquisition Corp. III and owns shares of Blue Water Acquisition Corp. III (BLUW) stock worth about $4.32M.
Signature
/s/ Joseph Hernandez
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Joseph Hernandez and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Create free account and return here Already have an account? Sign in and return here

Quick Takeaways

  • Joseph Hernandez has 5 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $15,808,160.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Blue Water Biotech, Inc. ($11,490,960).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Joseph Hernandez

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ONCO Blue Water Biotech, Inc. CEO, Director, 10%+ Owner $11,490,960 09 May 2023
BLUW, BLUWU Blue Water Acquisition Corp. III Chief Executive Officer, Director, 10%+ Owner $4,317,200 25 Nov 2025
BWIV, BWIV-UN Blue Water Acquisition Corp. IV Chief Executive Officer, Director, 10%+ Owner 23 Mar 2026
CRXT Clarus Therapeutics Holdings, Inc. Director 07 Jun 2022
CRXT CLARUS THERAPEUTICS INC Director, Former 10% owner 09 Sep 2021

Insider Transactions Reported by Joseph Hernandez:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .